← Back to Search

Social Support Intervention for Cancer Caregivers

N/A
Recruiting
Led By Erin E Kent, PhD, MS
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks, 8 weeks
Awards & highlights

Study Summary

This trial tests a social support intervention to help rural cancer caregivers find and use sources of support. It aims to help them cope with the demands of caregiving.

Who is the study for?
This trial is for caregivers of cancer patients with stage II-IV solid tumors or hematologic malignancies, who are receiving active treatment and live in rural areas. Caregivers must be adults, speak English, provide consent, and commit to the study's procedures. Patients' caregivers must also enroll in the study.Check my eligibility
What is being tested?
The enCompass Carolina program is being tested for its ability to help cancer caregivers find new support sources. It includes using an eco-mapping tool and caregiver-coach visits to assess if this social support intervention is feasible and effective in rural communities.See study design
What are the potential side effects?
Since this trial involves a social support intervention rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional or psychological impacts from engaging in the program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks, 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks, 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Study feasibility - Caregiver intervention engagement
Study feasibility - caregiver enrollment
Secondary outcome measures
Caregiver self-efficacy
Intervention acceptability-qualitative
Intervention acceptability-quantitative

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Caregiver of subject with cancerExperimental Treatment2 Interventions
Adults who identify as a primary unpaid caregiver for a rural-dwelling adult with cancer.
Group II: Subject with CancerActive Control1 Intervention
Subjects is with cancer and receive care from caregivers.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,183 Total Patients Enrolled
The Duke EndowmentOTHER
12 Previous Clinical Trials
39,792 Total Patients Enrolled
Erin E Kent, PhD, MSPrincipal InvestigatorDepartment of Health Policy and Management Gillings School of Global Public Health

Media Library

Caregiver of subject with cancer Clinical Trial Eligibility Overview. Trial Name: NCT05828927 — N/A
Cancer Research Study Groups: Subject with Cancer, Caregiver of subject with cancer
Cancer Clinical Trial 2023: Caregiver of subject with cancer Highlights & Side Effects. Trial Name: NCT05828927 — N/A
Caregiver of subject with cancer 2023 Treatment Timeline for Medical Study. Trial Name: NCT05828927 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation still available for those who wish to join the study?

"This medical trial, which was first published on May 15th 2023, is actively searching for patients. The details of the study were last revised on May 23rd 2023."

Answered by AI

How many subjects are being monitored in this research project?

"Correct. The clinicaltrials.gov website confirms that recruitment for this medical study is still ongoing; it was first posted on May 15th 2023 and the most recent update occured on May 23rd 2023. This clinical trial requires 150 patients to be recruiter from a single site."

Answered by AI
~84 spots leftby Jul 2025